Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAston Martin Lagonda Regulatory News (AML)

Share Price Information for Aston Martin Lagonda (AML)

Share Price is delayed by 15 minutes
Get Live Data
38.50    0.00 (0.00%)
Bid:
38.08
Ask:
38.50
Spread: 0.42 (1.103%)
Market Cap: £389.89m
AML Live PriceLast checked at - London Stock Exchange

Intraday Aston Martin Lagonda Share Chart

Independent Non-executive Director appointment

25 Feb 2025 10:00

RNS Number : 2827Y
Aston Martin Lagonda Glob.Hldgs PLC
25 February 2025
 

25 February 2025

 

Aston Martin Lagonda Global Holdings plc (the "Company")

Independent Non-executive Director appointment

 

Aston Martin Lagonda Global Holdings plc (the "Company" or "Aston Martin") announces the appointment of Vicky Jarman as an Independent Non-executive Director, Chair of the Audit & Risk Committee and member of the Nomination and Remuneration Committees. Vicky's appointment will take effect on 1 March 2025.

Vicky is currently a Non-executive Director at Great Portland Estates plc where she is Chair of the Audit Committee and a member of the Remuneration and Nomination Committees. Vicky has previously been a Non-executive Director and Chair of the Audit Committees at each of Equiniti Group plc, Hays plc and De La Rue plc and was Senior Independent Director at Equiniti Group plc. In addition, Vicky was previously a Non-executive Director of Melrose plc, Entain plc and Signature Aviation plc. 

Vicky started her career with KPMG and qualified as a Chartered Accountant before spending over 10 years with Lazard & Co Ltd, working in the Investment Banking team and then as Chief Operating Officer for the London and Middle East operations.

Lawrence Stroll, Executive Chairman of Aston Martin, said: "I am delighted to welcome Vicky to our Board. Vicky's significant financial, commercial and non-executive experience will be of great benefit to us. I look forward to working with Vicky over the coming years".

The Company confirms that there is no further information to be disclosed pursuant to paragraph 6.4.8R of the Listing Rules of the Financial Conduct Authority.

As previously announced on 13 December 2024, Robin Freestone will step down from the Board and his position as Chair of the Audit & Risk Committee on 28 February 2025. 

The Company further announces that Natalie Massenet and Cyrus Jilla, existing Non-executive Directors of the Company, have been appointed as members of the Nomination Committee with effect from 24 February 2025. 

ENDS

Enquiries

 

Investors and Analysts

James Arnold Head of Investor Relations +44 (0) 7385 222347

james.arnold@astonmartin.com

Ella South Investor Relations Analyst +44 (0) 7776 545420

ella.south@astonmartin.com

Media

 

Kevin Watters Director of Communications +44 (0) 7764 386683

kevin.watters@astonmartin.com

 

Paul Garbett Head of Corporate & Brand +44 (0) 7501 380799

Communications paul.garbettt@astonmartin.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADDGDDDSDDGUS
Date   Source Headline
9th Jun 202611:32 amRNSDirector/PDMR Shareholding
4th Jun 20267:00 amRNSIssue of equity to satisfy share awards
15th May 20267:00 amRNSIssue of equity to satisfy employee share awards
6th May 202612:51 pmRNSVoting results of AGM 2026
29th Apr 20267:00 amRNSQ1 results for three months ended 31 March 2026
25th Mar 20269:53 amRNSAnnual Financial Report
9th Mar 202612:12 pmRNSResult of Meeting
25th Feb 20267:00 amRNSPreliminary Results FY2025
20th Feb 20267:00 amRNSNotice of GM and FY 2025 Trading Update
29th Oct 20257:00 amRNSQ3 results for the quarter ended 30 September 2025
6th Oct 20257:00 amRNSQ3 2025 Trading Update and revised outlook
10th Sep 202511:33 amRNSDirector/PDMR Shareholding
5th Sep 20257:00 amRNSIssue of equity to satisfy employee share awards
30th Jul 20257:00 amRNSInterim results
28th Jul 20254:33 pmRNSDirectorate Change
27th May 202510:13 amRNSDirector/PDMR Shareholding
27th May 202510:12 amRNSDirector/PDMR Shareholding
15th May 202510:38 amRNSHolding(s) in Company
13th May 20255:26 pmRNSHolding(s) in Company
13th May 202510:33 amRNSDirector/PDMR Shareholding
13th May 202510:31 amRNSDirector/PDMR Shareholding
13th May 202510:26 amRNSDirector/PDMR Shareholding
12th May 20255:53 pmRNSHolding(s) in Company
12th May 20251:13 pmRNSHolding(s) in Company
12th May 202512:52 pmRNSHolding(s) in Company
7th May 20252:45 pmRNSDirector/PDMR Shareholding
7th May 20251:15 pmRNSResult of General Meeting and issue of equity
7th May 20251:07 pmRNSVoting Result of AGM
30th Apr 20257:00 amRNS1st Quarter Results
17th Apr 20258:57 amRNSNotice of General Meeting
16th Apr 20253:20 pmRNSDirector Declaration
31st Mar 20255:11 pmRNSStatement regarding media comments
31st Mar 20257:00 amRNSProposed investment by Yew Tree Consortium
26th Mar 20259:24 amRNSAnnual Financial Report
26th Feb 20257:00 amRNSPreliminary results year ended 31 December 2024
25th Feb 202510:00 amRNSIndependent Non-executive Director appointment
7th Feb 20255:29 pmRNSHolding(s) in Company
13th Dec 20249:00 amRNSDirectorate Change
4th Dec 20244:00 pmRNSHolding(s) in Company
29th Nov 20244:15 pmRNSHolding(s) in Company
29th Nov 20241:01 pmRNSHolding(s) in Company
29th Nov 202412:46 pmRNSDirector/PDMR Shareholding Replacement
29th Nov 202412:18 pmRNSDirector/PDMR Shareholding
29th Nov 202412:17 pmRNSDirector/PDMR Shareholding
29th Nov 202412:11 pmRNSDirector/PDMR Shareholding
27th Nov 20247:00 amRNSResult of Equity Issue
26th Nov 20245:06 pmRNSIssue of Equity
26th Nov 20244:58 pmRNSIssue of Equity
6th Nov 202410:37 amRNSDirector/PDMR Shareholding
30th Oct 20247:00 amRNS3rd Quarter Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.